New bicyclic cannabinoid receptor-1 (CB1-R) antagonists

被引:38
作者
Carpino, PA [1 ]
Griffith, DA [1 ]
Sakya, S [1 ]
Dow, RL [1 ]
Black, SC [1 ]
Hadcock, JR [1 ]
Iredale, PA [1 ]
Scott, DO [1 ]
Fichtner, MW [1 ]
Rose, CR [1 ]
Day, R [1 ]
Dibrino, J [1 ]
Butler, M [1 ]
DeBartolo, DB [1 ]
Dutcher, D [1 ]
Gautreau, D [1 ]
Lizano, JS [1 ]
O'Connor, RE [1 ]
Sands, MA [1 ]
Kelly-Sullivan, D [1 ]
Ward, KM [1 ]
机构
[1] Pfizer Global Res & Dev, Groton Labs, Groton, CT 06340 USA
关键词
cannabinoid receptor antagonists; CB1-R; 2,6-dihydropyrazolo[4,3-d]pyrimidin-7-one; 2,6-dihydro-pyrazolo[3,4-c]pyridin-7-one; 2,6-dihydro-pyrazolo[3,4-d]pyridazin-7-one; 1,9-dihydro-purin-6-one; obesity; conformational restriction;
D O I
10.1016/j.bmcl.2005.10.019
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of conformationally constrained bicyclic derivatives derived from SR141716 was prepared and evaluated as hCB(1)-R antagonists and inverse agonists. Optimization of the structure-activity relationships around the 2,6-dihydro-pyrazolo[4,3 -d]pyrimidin-7-one derivative 2a led to the identification of two compounds with oral activity in rodent feeding models (2h and 4a). Replacement of the PP group in 2h with other bicyclic groups resulted in a loss of binding affinity. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:731 / 736
页数:6
相关论文
共 50 条
  • [1] Recent advances in CB1 cannabinoid receptor antagonists
    Lange, JHM
    Kruse, CG
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2004, 7 (04) : 498 - 506
  • [2] 1,2,3-Triazole derivatives as new cannabinoid CB1 receptor antagonists
    Hou, Duen-Ren
    Alam, Safiul
    Kuan, Ting-Chun
    Ramanathan, Mani
    Lin, Tsung-Pang
    Hung, Ming-Shiu
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 1022 - 1025
  • [3] Cannabinoid CB1 receptor antagonists in therapeutic and structural perspectives
    Lange, Jos H. M.
    Kruse, Chris G.
    CHEMICAL RECORD, 2008, 8 (03) : 156 - 168
  • [4] Use of cannabinoid CB1 receptor antagonists for the treatment of metabolic disorders
    Scheen, Andre J.
    Paquot, Nicolas
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (01) : 103 - 116
  • [5] Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB1R) Antagonist
    Liu, Ziyi
    Iyer, Malliga R.
    Godlewski, Grzegorz
    Jourdan, Tony
    Liu, Jie
    Coffey, Nathan J.
    Zawatsky, Charles N.
    Puhl, Henry L.
    Wess, Jurgen
    Meister, Jaroslawna
    Liow, Jeih-San
    Innis, Robert B.
    Hassan, Sergio A.
    Lee, Yong Sok
    Kunos, George
    Cinar, Resat
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2021, 4 (03) : 1175 - 1187
  • [6] Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonist
    van Oosten, BW
    Killestein, J
    Mathus-Vliegen, EMH
    Polman, CH
    MULTIPLE SCLEROSIS, 2004, 10 (03): : 330 - 331
  • [7] Diaryl piperidines as CB1 receptor antagonists
    Scott, Jack D.
    Li, Sarah W.
    Wang, Hongwu
    Xia, Yan
    Jayne, Charles L.
    Miller, Michael W.
    Duffy, Ruth A.
    Boykow, George C.
    Kowalski, Timothy J.
    Spar, Brian D.
    Stamford, Andrew W.
    Chackalamannil, Samuel
    Lachowicz, Jean E.
    Greenlee, William J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 1278 - 1283
  • [8] The cannabinoid CB1 receptor is expressed in pancreatic δ-cells
    Tharp, William G.
    Lee, Yong-Ho
    Maple, Rhonda L.
    Pratley, Richard E.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 372 (04) : 595 - 600
  • [9] Pentacycle derivatives as cannabinoid CB1 receptor ligands
    Lee, Suk Ho
    Seo, Hee Jeong
    Kim, Min Ju
    Kang, Suk Youn
    Lee, Sung-Han
    Ahn, Kwangwoo
    Lee, MinWoo
    Han, Ho-Kyun
    Kim, Jeongmin
    Lee, Jinhwa
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (23) : 6632 - 6636
  • [10] Thienopyrimidinone bis-aminopyrrolidine ureas as potent melaninconcentrating hormone receptor-1 (MCH-R1) antagonists
    Zhang, Mingzhu
    Tamiya, Junko
    Nguyen, Linh
    Rowbottom, Martin W.
    Dyck, Brian
    Vickers, Troy D.
    Grey, Jonathan
    Schwarz, David A.
    Heise, Christopher E.
    Haelewyn, Jason
    Mistry, Monica S.
    Goodfellow, Val S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (09) : 2535 - 2539